Siga Technologies (SIGA) Finished Goods (2019 - 2025)
Siga Technologies' (SIGA) quarterly Finished Goods came in at $6.8 million in Q4 2025, down 24.49% on a YoY basis from $9.0 million in Q4 2024, and little changed quarter-over-quarter from $6.8 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Finished Goods (2019 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Finished Goods for 7 consecutive years, with $6.8 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Finished Goods fell 24.49% year-over-year to $6.8 million; the trailing twelve-month figure through Dec 2025 stood at $6.8 million (down 24.49% YoY), and the FY2025 full-year result was $6.8 million, down 24.49% from the prior year.
- Finished Goods was little changed at $6.8 million in Q4 2025 per SIGA's latest filing, from $6.8 million in the prior quarter.
- Across five years, Finished Goods topped out at $17.5 million in Q1 2025 and bottomed at $537497.0 in Q2 2024.
- Historically, Finished Goods has averaged $5.8 million across 5 years, with a median of $6.0 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Finished Goods jumped 1868.7% in 2021, then slumped 94.03% in 2024.
- Over 5 years, Finished Goods stood at $2.0 million in 2021, then surged by 188.14% to $5.9 million in 2022, then plunged by 57.25% to $2.5 million in 2023, then soared by 259.52% to $9.0 million in 2024, then decreased by 24.49% to $6.8 million in 2025.
- According to Business Quant data, Finished Goods over the past three periods registered $6.8 million, $6.8 million, and $4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.80 Mn |
| Sep 30, 2025 | 6.79 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | 17.51 Mn |
| Dec 31, 2024 | 9.01 Mn |
| Sep 30, 2024 | 10.47 Mn |
| Jun 30, 2024 | 537,497.00 |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 2.51 Mn |
| Sep 30, 2023 | 9.91 Mn |
| Jun 30, 2023 | 9.01 Mn |
| Mar 31, 2023 | 6.06 Mn |
| Dec 31, 2022 | 5.86 Mn |
| Sep 30, 2022 | 6.16 Mn |
| Jun 30, 2022 | 7.12 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Sep 30, 2021 | 1.65 Mn |
| Jun 30, 2021 | 1.74 Mn |
| Mar 31, 2021 | 2.08 Mn |